Form 4 for MET MetLife
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001099219-23-000073 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-03-02 | 2023-02-28 | MET | DEBEL MARLENE | EVP, CRO | A - Grant | — | +37.7K | 60.8K | +163% | — |
| DM | 2023-03-02 | 2023-02-28+ | MET | DEBEL MARLENE | EVP, CRO | F - Tax | $71.66 | -16.9K | 76.1K | -18% | -$1.21M |
| D | 2023-03-02 | 2023-02-28 | MET | DEBEL MARLENE | EVP, CRO | A - Grant | $0.00 | +16.6K | 16.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | A | A | 32,193 | — | 93,034 | D | — | — | (F2) Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. |
| 2 | Common | Common Stock | 2023-02-28 | A | A | 5,542 | — | 60,841 | D | — | — | (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan. |
| 3 | Common | Common Stock | 2023-02-28 | F | D | 14,368 | $71.73 | 78,666 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-01 | F | D | 2,548 | $71.27 | 76,118 | D | — | — | |
| 5 | Derivative | Employee Stock Options (right to buy) | 2023-02-28 | A | A | 16,625 | $0.00 | 16,625 | D | $71.73 · — to 2033-02-27 | 16,625 Common Stock | (F5) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date. |